NIH continues to boost national
COVID-19 testing capacity
New laboratory and point-of-care tests to
enable access and rapid results
The National Institutes of Health today announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative. NIH is awarding contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours.
Learn more about the companies that have achieved key RADx milestones and will receive support for manufacturing and scale up.
.png)
No hay comentarios:
Publicar un comentario